University at Buffalo research on acetylcholine receptors (AChR) will help pharmacologists better understand how drugs work and could help make “receptor engineering” a reality.
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.
Nine faculty and one staff member from the School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 11th annual UB Celebration of Faculty and Staff Academic Excellence.
Along with her trainees, Gabriela K. Popescu, PhD, professor of biochemistry, organized an international meeting of researchers studying glutamate-gated neurotransmitter receptors.
Wilma A. Hofmann, PhD, assistant professor of physiology and biophysics, will study cellular processes that cause high levels of unsaturated fats to increase the metastatic potential of prostate cancer cells.
A recent graduate, doctoral candidates and postdoctoral scholars in the University at Buffalo’s Neuroscience Program have received Beverly Petterson Bishop and Charles W. Bishop Neuroscience Fund Awards.
Anthony L. Auerbach, PhD, professor of physiology and biophysics, will further develop ‘energy maps’ detailing the microscopic changes that occur as neurotransmitters activate protein receptors in a cell’s membrane.
Zhen Yan, PhD, professor of physiology and biophysics, has received $1.6 million to continue her study of human dopamine D4 receptor variants — a type of neurotransmitter receptor in the brain’s prefrontal cortex.
Stephen Rudin, PhD, SUNY Distinguished Professor of radiology and director of radiation physics, has been honored with the 2014 Stockton Kimball Award for outstanding scientific accomplishment as well as significant service to the university.